To the Editor: Nonpandemic infectious diseases occur with usual incidence during pandemics even though clinical attention is often on the pandemic pathogen. Many of these other infectious diseases share similar clinical signs and symptoms and are sometimes fatal. During the outbreak of pandemic (H1N1) 2009, tissue specimens from case-patients with undiagnosed fatal respiratory illnesses were submitted to the Infectious Diseases Pathology Branch at the Centers for Disease Control and Prevention (Atlanta, Georgia, USA) for evaluation for pandemic (H1N1) 2009 virus infection (1) .
All respiratory tissue specimens from 450 case-patients received during April 29, 2009-May 5, 2010, were screened by the Centers for Disease Control and Prevention real-time reverse transcription PCR (rRT-PCR) protocol for detection and characterization of swine infl uenza virus (2) . Of these, specimens from 250 (56%) tested negative for pandemic (H1N1) 2009 virus and had no other confi rmatory or prior infl uenza testing. Of these case-patients whose specimens tested negative for pandemic (H1N1) 2009 virus, a total of 139 (56%) were male, and the median age was 30 years (range 8 days to 81 years). The median duration from onset of illness to death was 7 days (range 1-40 days infections. Although we did not conduct a case-control study, these fi ndings also support the results of other studies that previously reported the demographic characteristics of patients with pandemic infl uenza infections and the risk factors for severe or fatal pandemic infl uenza infections (3, 4) , especially with respect to obesity (5). Evaluation of tissues collected during autopsy from patients with a suspected infectious process can provide an etiologic diagnosis that was not available from routine premortem and postmortem testing. Other etiologic agents detected in this study included reportable disease agents (e.g., Rickettsia rickettsii, Legionella pneumophila, dengue virus), vaccine-preventable diseases (e.g., pneumococcal, meningococcal diseases), and zoonotic agents (Leptospira and Capnocytophaga spp.). These fi ndings underscore the need for autopsies for diagnosing fatal infectious diseases (6) . They also confi rm the need for coordinated surveillance programs that identify deaths potentially attributable to infectious causes, including the unexplained deaths program (7) and medical examiner infectious diseases death surveillance program (8) . Partnerships of medical examiners and pathologists with local, state, and federal public health departments are crucial for detecting and monitoring pandemic diseases and for assessing the scope and magnitude of infectious agents that continuously affect human populations (9) . These infections often result in sudden or unexplained death; thus, a standardized approach to death investigations is recommended.
Epidemic Meningococcal Meningitis, Cameroon
To the Editor: In 2010, the city of Ngaoundéré in Cameroon experienced its fi rst reported epidemic of meningococcal meningitis. Ngaoundéré, with an estimated population of 180,000, is the main city in the Adamaoua region in northern Cameroon. The 2 northernmost regions of Cameroon, North and Far North, are considered to belong to the African meningitis belt (1) and are periodically affected by meningococcal meningitis outbreaks. However, the Adamaoua region had been spared because of its altitude, latitude, and low population density in comparison with the North and Far North regions. Fewer than 10 sporadic cases have been reported in the Adamaoua region every year.
